Thymoglobulin: SANG completed enrollment in its Phase III study of Thymoglobulin

SangStat Medical Corp. (SANG), Menlo Park, Calif. Product: Thymoglobulin Indication: Treat acute rejection Status: SANG completed enrollment in its Phase III study of Thymoglobulin and expects to rel...